Table 1.
Sociodemographic, clinical and hospital characteristics of amphetamine-related hospitalisations by diagnostic priority, 2014
| Characteristic | Any diagnosis, n (%) n=1 47 020 |
Primary diagnosis, n (%) n=8560 |
| Age | ||
| 18–44 | 95 095 (64.7) | 6410 (74.9) |
| 45–64 | 48 985 (33.3) | 1950 (22.8) |
| 65+ | 2940 (2.0) | 200 (2.3) |
| Sex | ||
| Male | 88 145 (60.0) | 5615 (65.6) |
| Female | 58 875 (40.0) | 2945 (34.4) |
| Race | ||
| White | 101 135 (68.8) | 6435 (75.2) |
| Black | 11 955 (8.1) | 605 (7.1) |
| Hispanic | 23 430 (15.9) | 1085 (12.7) |
| Asian or Pacific Islander | 4525 (3.1) | 155 (1.8) |
| Native American | 2725 (1.9) | 80 (0.9) |
| Other | 3250 (2.2) | 200 (2.3) |
| Primary payer | ||
| Medicare | 21 290 (14.5) | 1130 (13.2) |
| Medicaid | 73 455 (50.0) | 3080 (36.0) |
| Private insurance | 19 895 (13.5) | 1540 (18.0) |
| Self-pay | 24 365 (16.6) | 2190 (25.6) |
| No charge | 1360 (0.9) | 160 (1.9) |
| Other | 6655 (4.5) | 460 (5.4) |
| Median household income | ||
| First quartile (US$1–US$39 999) | 54 250 (36.9) | 3300 (38.6) |
| Second quartile (US40 000–US$50 999) | 42 405 (28.8) | 2325 (27.2) |
| Third quartile (US$51 000–US$65 999) | 31 645 (21.5) | 1795 (21.0) |
| Fourth quartile (US$66 000+) | 18 720 (12.7) | 1140 (13.3) |
| Length of stay | ||
| 0–2 days | 53 730 (36.5) | 4685 (54.7) |
| >2 days | 93 290 (63.5) | 3875 (45.3) |
| Discharge disposition | ||
| Routine | 112 885 (76.8) | 6205 (72.5) |
| Transfer to short-term Hospital | 2885 (2.0) | 150 (1.8) |
| Transfer other* | 14 120 (9.6) | 1110 (13.0) |
| Home healthcare | 3840 (2.6) | † |
| Against medical advice | 11 105 (7.6) | 880 (10.3) |
| Died | 2000 (1.4) | 110 (1.3) |
| Discharge alive, destination unknown | 185 (0.1) | † |
| Total Elixhauser groups per record | ||
| 0–2 | 55 785 (37.9) | 3930 (45.9) |
| 3–4 | 55 725 (37.9) | 3285 (38.4) |
| 5–6 | 25 000 (17.0) | 1050 (12.3) |
| 7+ | 10 510 (7.1) | 295 (3.4) |
| Hospital bedsize‡ | ||
| Small | 23 880 (16.2) | 1515 (17.7) |
| Medium | 33 735 (22.9) | 2415 (28.2) |
| Large | 89 405 (60.8) | 4630 (54.1) |
| Hospital ownership/control | ||
| Government, non-federal | 30 280 (20.6) | 1475 (17.2) |
| Private, not-profit | 93 145 (63.4) | 5440 (63.6) |
| Private, invest-own | 23 595 (16.0) | 1645 (19.2) |
| Hospital location/teaching status | ||
| Rural | 11 960 (8.1) | 985 (11.5) |
| Urban nonteaching | 44 785 (30.5) | 2615 (30.5) |
| Urban teaching | 90 275 (61.4) | 4960 (57.9) |
| Hospital region | ||
| Northeast | 4930 (3.4) | 440 (5.1) |
| Midwest | 16 800 (11.4) | 1280 (15.0) |
| South | 36 205 (24.6) | 3290 (38.4) |
| West | 89 085 (60.6) | 3550 (41.5) |
*Includes skilled nursing facility, intermediate care facility and other types of facilities.
†Data suppressed —10 or fewer observations in some cells.
‡Hospital bedsize describes overall a hospital’s size based on its number of short-term acute care beds, location and teaching status. There is no fixed threshold used to denote small, medium and large bedsize hospitals. Additional details on hospital bedsize are available on the HCUP website (www.hcup-us.ahrq.gov).
HCUP, Healthcare Cost and Utilisation Project.